Available since 2013, the innovative ONCOblot blood test identifies the existence of malignant cancer cells in such small numbers that it is easy to destroy them before they grow into a clinically significant cancer. The test works by detecting ENOX2 proteins, which are produced only by cancer cells, and then shed into the circulation. By identifying where in the body the ENOX2 proteins originated, ONCOblot can tell us where the cancer is. Because the proteins become detectable when the malignant cells reach 2 million—which is extremely low compared with other screening techniques — ONCOblot is becoming a much more powerful tool than traditional screening methods.
The ONCOblot test can detect the presence of dozens of cancers, including: bladder, breast, cervical, colorectal, endometrial, esophageal, kidney, leukemia, liver, lung, lymphoma, melanoma, mesothelioma, myeloma, ovarian, pancreatic, sarcoma, stomach, thyroid, and uterine.
Our goal at Agenixs is to give you as much information as possible about your body and your health, so we can take the necessary steps to ensure a long, joyous, and fulfilling life.
Today, the majority of cancers are diagnosed too late, when outcomes are poor. That’s why we’re excited to offer the Galleri™ multi-cancer early detection test* to our patients. This first-of-its-kind test detects more than 50 types of cancer through a simple blood draw.
When cancer is detected in its early stages, more cancer treatment options may be available that can improve survival rates. Be in control of your health and call us today to make an appointment to learn more and determine if the test may be right for you.
*The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. It is intended to be used in addition to, and not replace, other cancer screening tests.
